Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Quantifying the early stages of remyelination following cuprizone-induced demyelination.
National MS Society: Postdoctoral Fellowships
Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS.
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial.
IL-2Rβγ-signaling contributes to regulatory T cell maintenance and stability in daclizumab HYP-treated RRMS patients
Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination.
Cigarette smoking and autoimmune disease: what can we learn from epidemiology?
In vitro and in vivo pharmacological models to assess demyelination and remyelination.
Sex differences in autoimmune diseases.
De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected.
Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis.
TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.
Testosterone treatment in multiple sclerosis: a pilot study.
GlaxoSmithKline Protocol Summaries: Firategrast
National MS Society: Sylvia Lawry Physician Fellowships
Webinar: Solutions for Genome Editing: TALEN, CRISPR, & Safe Harbor Integration
Teriflunomide modest help but safe for MS
A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity.
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex (SYNERGY)
MRI identification of the rostral-caudal pattern of pathology within the corpus callosum in the cuprizone mouse model.
Immunopathogenesis of neuromyelitis optica.
Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?
Experimental models of spontaneous autoimmune disease in the central nervous system.
Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study.
[Usefulness of electronic drug registers: Spanish register of patients treated with fingolimod (Gilenya ®)].

Pages